Novartis Patient Assistance Foundation: $2.8B Revenue, $2.3B Program Expenses

The composite efficiency score of 60/100 puts Novartis Patient Assistance Foundation at C — neither standout nor failing. Some factors run above the median (typically program spending) while others run below (typically reserves or trend stability).

On revenue, Novartis Patient Assistance Foundation is among the largest U.S. nonprofits: $2.8B in 2023 reported revenue. Organizations at this scale typically operate hospitals, university systems, or national federations — the financial pattern looks more like a corporation than the small-charity stereotype. Novartis Patient Assistance Foundation directs 80% of its expenses to programs — above the third-party-rater threshold for an efficient organization.

Five-year revenue trajectory is strongly positive: Novartis Patient Assistance Foundation has grown materially in real terms, which usually signals successful fundraising and program expansion. CEO compensation is reported as zero in the filing — typical for nonprofits where the chief executive is paid through a related entity (parent system, university, or foundation) rather than the filing organization itself, or for small organizations whose chief is a volunteer or board member. Novartis Patient Assistance Foundation is categorized under Health — the largest segment of U.S. nonprofit revenue, dominated by hospitals, hospital systems, and health-research organizations. Revenue-to-program ratios in this category often look different from smaller-program nonprofits because the underlying operations are capital-intensive.